Endeavor Biomedicines, Inc.
5 clinical trials · Sponsor
◉ Watch Endeavor Biomedicines, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants (NCT07454291) | Endeavor Biomedicines, Inc. | 2026-04-28 |
| A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial) (NCT06422884) | Endeavor Biomedicines, Inc. | 2024-11-15 |
| A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations (NCT05199584) | Endeavor Biomedicines, Inc. | 2022-05-24 |
| A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT04968574) | Endeavor Biomedicines, Inc. | 2021-08-26 |
Track Endeavor Biomedicines, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.